An analysis into mild AD individuals who showed both Aβ and tau positivity showed the same qualitative results, although cognition became more closer to MRI measures in effectiveness (and required sample sizes were generally smaller, due to more pronounced longitudinal changes in this more highly selected group). Here, MAPT is linked to Alzheimer disease.